Conference space still available……….
Dr. Barkley returns to Minneapolis for three separate presentations – November 12, 13, 14, 2014
Doubletree by Hilton, 7800 Normandale Blvd, Minneapolis, MN 55439. Call 952-835-7800 by 10/12/14 to reserve room.
PARENTS AND EDUCATORS: Addressing the Issues in the Transition from Child to Adolescent to Adult ADHD
Wednesday, November 12, 2014 • 6:30 PM–8:00 PM
Advances in the Understanding & Management of ADHD in Children and Adolescents (CME and Professional CEU’s available)
Thursday, November 13, 2014 • 8:45 AM–4:30 PM
ADHD in Adults: Diagnosis, Impairments, and Management(CME and Professional CEU’s available)
Friday, November 14, 2014 8:45 am -12:15pm
Complete conference descriptions below
Parents and Educators:
Addressing the Issues in the Transition from Child to Adolescent to Adult ADHD
Wednesday, November 12, 2014 • 6:30 PM–8:00 PM
Cost: $40 per person (payment via credit card subject to small processing fee) Please note no refunds will be given.
The nature of ADHD changes with age. So do the demands placed upon children as they enter adolescence and then on to adulthood. New settings, people, and opportunities more generally become available during these transitions that were not so for children. These also pose a new set of risks for people with ADHD and their families as they make these transitions. This presentation describes the various changes that take place in the nature of ADHD from childhood to adolescence and then to adulthood as well as in the new risks each transition poses for potential impairments in various major life activities that were not issues in childhood. Dr. Barkley will discuss ways that families can address these risks and issues to form better strategies to help children and young adults meet and cope with the challenges.
Advances in the Understanding & Management of ADHD in Children and Adolescents
CME and Professional CEU’s:
Thursday, November13, 2014 • 8:45 AM–4:30 PM
Cost: $185 by 10/12/14, $215 after. Discount to attend both professional conferences. (payment via credit card subject to small processing fee) Please note no refunds will be given.
Continental breakfast, Lunch and Snack included
Conference Objectives:
1. Define five major executive functions and their deficits in people with ADHD.
2. Describe implications of this model for deeper understanding of ADHD and more effective interventions.
3. Delineate SCT symptoms and differences from ADHD symptoms.
4. Describe treatment research and its implications for management of SCT.
5. Explain the role of emotional self-regulation in understanding nature of ADHD in assessment and management of ADHD.
6. Describe the various medication types and delivery systems now available and FDA approved for medication management, including the beneficial effects and potential side effects.
Schedule and Sessions:
8:45-9:00 Registration (Continental Breakfast included)
9:00-10:30: ADHD, Self-Regulation, and Executive Functioning: Theory and Implications for Management
Dr. Barkley has developed one of the leading theories of executive functioning and its role in the nature of ADHD. This theory is based on understanding the nature of the executive neuropsychological functions as a multi-level meta-construct and its contribution to self-regulation across time to support the individual’s long-term goals and general welfare. This model views EF not just as a suite of purely cognitive capacities but as an extended phenotype from brain functioning into ever widening spheres of daily adaptive, self-reliant, and cooperative social functioning across the major domains of daily life activities in which humans must function effectively to survive and prosper. From this theory, he has developed numerous clinical implications concerning the diagnosis, assessment, and management of ADHD. Specific management principles will be developed from the theory that extends across multiple domains of major life activities.
10:30-10:45 Break
10:45-12:15: The Other Attention Disorder: Sluggish Cognitive Tempo (or ADD) versus ADHD
Sluggish Cognitive Tempo, a second attention disorder, has been largely ignored for nearly two centuries until the mid-1980s when studies of children having ADD without Hyperactivity suggested that an important subset had a relatively distinct pattern of symptoms not central to ADHD. These symptoms included daydreaming, mental fogginess and confusion, staring, slow processing of information, hypoactivity, slow movement, and lethargy, among others. Dr. Barkley reviews the history of SCT and what is known about it from past research. He also describes the results of his own recent investigations into SCT in children and the only study of SCT in adults that he recently published, all of which suggest that SCT is a distinct disorder from ADHD but one that may overlap with it in nearly half of all cases. Dr. Barkley discusses the differences between SCT in symptoms, executive functioning, comorbidity for other disorders, and psychosocial impairment and what little is known about differential treatment response. He also discusses several different possibilities for explaining the underlying nature of SCT.
12:15-1:15 Lunch, included
1:15-2:45: The Importance of Emotion in Understanding and Managing ADHD
ADHD is currently understood to be a disorder of inattention, impulsivity, and usually hyperactivity that arises in childhood or early adolescence and is highly persistent over time in most cases. However, since the first medical papers have been published on ADHD starting in 1798, emotion has always been included in the conceptualization of the disorder up through the 1970s. But beginning with DSM-II and progressing to the present, emotional dysregulation has been excluded from the clinical conceptualization of the disorder and the diagnostic criteria and relegated to an associated problem or the result of comorbid disorders. This presentation reviews the evidence from the history, neuropsychology, neuro-anatomy, and observational research that shows that emotional impulsiveness and deficient emotional self-regulation are an integral part of ADHD. Returning emotion to its rightful place as a core feature of the disorder also serves to better explain the development of comorbid disorders, such as oppositional defiant disorder, and well as various life course impairments. Dr. Barkley will discuss how to determine which aspects of emotional adjustment problems in ADHD cases are the result of the disorder and which are likely to be the consequence of comorbidity or other life course circumstances. He will also address the implications of including emotion in ADHD for its management.
2:45-3:00 Break, snacks
3:00-3:15: Advances in Medication Management of ADHD
The past 10-15 years have witnessed a number of major developments in the medications and delivery systems available for the management of ADHD. Dr. Barkley here discusses the types of medications now available to ADHD management and the various delivery systems developed to extend the effectiveness of the medications across the day. For each medication, he will present the major beneficial effects and side effects. He will also discuss various issues clinicians should consider in selecting particular medications to use with a patient with ADHD, such as those issues related to the social context, the patient’s characteristics, and any comorbid conditions that may exist.
4:00-4:30 : Questions and Answers
ADHD in Adults: Diagnosis, Impairments, and Management
CME and Professional CEU’s
Friday, November 14, 2014 8:45 am -12:15pm
Cost: $85 by 10/12/14, $110 after. Discount to attend both professional conferences. (payment via credit card subject to small processing fee) Please note no refunds will be given.
Continental breakfast included
ADHD is now recognized as a relatively common mental disorder of teens and adults, affecting 4 to 5 percent of the adult population and accounting for an increasing number of referrals to mental health and family practices in this country. The disorder has a pervasive impact on most major domains of daily life activities, including occupational, educational, and social functioning and health-related behaviors. It is imperative that mental health, medical, and educational professionals have as much up-to-date knowledge of this adult disorder and its treatment as possible.
Conference Objectives:
1. Identify primary characteristics of ADHD and its typing in adults
2. Discern factors involved in evaluating ADHD and adjustments required to the DSM-5 for adults.
3. Describe the likely comorbid disorders and adaptive impairments associated with ADHD.
4. Describe overview of the theory of ADHD as a disorder of executive functioning and self-regulation and the many implications of this theory for management.
5. List proven treatments for ADHD in adults.
6. Describe most useful school and workplace accommodations for adults with ADHD.
Schedule and Sessions:
8:45 am-9:00 am: Registration , continental breakfast included
9:00-10:30 am: Current Diagnostic Criteria (DSM-5) and Adjustments, Typing of ADHD-Discovery of a second Attention Disorder (SCT), Comorbidity and Impairments in Adults with ADHD
10:30-10:45: break
10:45-12:15: Assessment of Adult ADHD, Treatment Options for Adult ADHD, Questions and Answers
This 3 hour presentation will provide current information on the nature, comorbid disorders, adaptive impairments, and underlying nature of ADHD as it occurs in adults. Dr. Barkley will provide guidance on the diagnosis and assessment of ADHD and the need for clinical judgment beyond just employing a DSM-5 algorithm. He will also describe the most effective treatment strategies focusing particularly on counseling, medication, cognitive-behavioral therapy for executive function deficits, and educational and workplace accommodations.
Target Audience: Parents, educators, and others working with youth diagnosed with ADHD.
CEU’s will be available.
Target Audience: Psychiatrists, Pediatricians, Child Neurologists, Primary Care and Family Medicine Practitioners, Psychologists, Social Workers, and Educators. Parents may also wish to attend but should understand that the program is intended for a professional audience.
Accreditation: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Minnetonka Medical Association and Southlake Pediatrics and ADHD Life Tools. The Minnesota Medical Association (MMA) is accredited by the Accreditation Council for Continuing for Continuing Medical Education to provide continuing medical education for physicians.
The Minnesota Medical Association designates this live activity for maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CEU’S: 6 Continuing Education Credits will be available for educators, nurses, psychologists and social workers. PrairieCare has received approval from Minnesota Board of Behavioral Health Therapy -LPC/LPCC, Minnesota Board of Behavioral Health Therapy -LADC, Minnesota Board of Marriage and Family Therapy (CE: 2014-040), Minnesota Board of Psychology (201402.136), and Minnesota Board of Social Work (CEP-70).
Target Audience:
Psychiatrists, Pediatricians, Child Neurologists, Primary Care and Family Medicine Practitioners, Psychologists, Social Workers, and Educators. Parents may also wish to attend but should understand that the program is intended for a professional audience.
Accreditation:This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Minnetonka Medical Association and Southlake Pediatrics and ADHD Life Tools. The Minnesota Medical Association (MMA) is accredited by the Accreditation Council for Continuing for Continuing Medical Education to provide continuing medical education for physicians.
The Minnesota Medical Association designates this live activity for maximum of 3.35 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CEU’S: 3 Continuing Education Credits will be available for educators, nurses, psychologists and social workers. ADHD Life Tools has received approval from Minnesota Board of Behavioral Health Therapy -LPC/LPCC (2014. CE. 082), Minnesota Board of Behavioral Health Therapy -LADC (2014.CE.ADC.023) , Minnesota Board of Marriage and Family Therapy (CE:2014-162), Minnesota Board of Psychology (201407.003), and Minnesota Board of Social Work (CEP-801).
